Picture of Glaukos logo

GKOS Glaukos Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Glaukos, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line15.4-120-49.6-99.2-135
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items48.783.442.14853.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4.47-3.223.58-13.4-10.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.369-2324.7-33.1-57.8
Capital Expenditures-4.72-6.93-47.8-30.3-20.2
Purchase of Fixed Assets
Other Investing Cash Flow Items48.1-198-10.47534.3
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities43.4-205-58.244.814.1
Financing Cash Flow Items-5.6-49.28.98-2.43-3.27
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-9.6426339.36.2515
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash33.234.43.9616.5-27.3